Crandell Keith's Form 4 filing
Neumora Therapeutics, Inc. (NMRA) · filed Sep 20, 2023
- Accession no.
- 0000899243-23-019274
- Filed
- Sep 20, 2023, 6:16 AM ET
- Trade date
- Sep 19, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 5 derivative transactions. Open-market purchases total $25.5M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Crandell KeithCIK 0001219039 | 10% Owner |
| Nelsen RobertCIK 0001219042 | 10% Owner |
| Bybee ClintonCIK 0001219043 | 10% Owner |
| Gillis StevenCIK 0001229592 | 10% Owner |
| ARCH Venture Partners X, LLCCIK 0001769012 | 10% Owner |
| ARCH Venture Fund XII, L.P.CIK 0001906837 | 10% Owner |
| ARCH Venture Partners XII, LLCCIK 0001979548 | 10% Owner |
| ARCH Venture Partners XII, L.P.CIK 0001979765 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2023 | Common Stock | CConversionAcquired | +684,167 | – | – | 684,167 | Indirect | Duplicate filing |
| Sep 19, 2023 | Common Stock | CConversionAcquired | +1,144,973 | – | – | 1,144,973 | Indirect | Duplicate filing |
| Sep 19, 2023 | Common Stock | CConversionAcquired | +6,895,021 | – | – | 12,205,379 | Indirect | Duplicate filing |
| Sep 19, 2023 | Common Stock | CConversionAcquired | +6,576,400 | – | – | 11,886,758 | Indirect | Duplicate filing |
| Sep 19, 2023 | Common Stock | CConversionAcquired | +2,124,143 | – | – | 2,124,143 | Indirect | Duplicate filing |
| Sep 19, 2023 | Common Stock | PPurchaseAcquired | +1,500,000 | $17.00 | +$25,500,000 | 3,624,143 | Indirect | Duplicate filing |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2023 | Common Stock | CConversionDisposed | −684,167 | – | – | 0 | Indirect | Duplicate filing |
| Sep 19, 2023 | Common Stock | CConversionDisposed | −1,144,973 | – | – | 0 | Indirect | Duplicate filing |
| Sep 19, 2023 | Common Stock | CConversionDisposed | −6,895,021 | – | – | 0 | Indirect | Duplicate filing |
| Sep 19, 2023 | Common Stock | CConversionDisposed | −6,576,400 | – | – | 0 | Indirect | Duplicate filing |
| Sep 19, 2023 | Common Stock | CConversionDisposed | −2,124,143 | – | – | 0 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.